Transcription of CIRCULAR OF INFORMATION - AABB
{{id}} {{{paragraph}}}
DO NOT COPYCIRCULAR OFINFORMATIONFOR THE USE OF human blood AND blood COMPONENTSThis CIRCULAR was prepared jointly by AABB, the AmericanRed Cross, America s blood Centers, and the Armed Ser-vices blood Program. The Food and Drug Administrationrecognizes this CIRCULAR of INFORMATION as an acceptableextension of container Law prohibits dispensing the blood and blood compo-nents described in this CIRCULAR without a NOT COPYT able of ContentsNotice to All Users .. 1 General INFORMATION for Whole blood and All blood Components .. 1 Donors .. 1 Testing of Donor blood .. 2 blood and component Labeling .. 3 Instructions for Use .. 4 Side Effects and Hazards for Whole blood and All blood Components .. 5 Immunologic Complications, Immediate .. 5 Immunologic Complications, Delayed.. 7 Nonimmunologic Complications .. 8 Fatal Transfusion Reactions.
1 D O N O T C O P Notice to All Users Y The Circular of Information for the Use of Human Blood and Blood Components (hereafter referred to as Circular) is an extension of container labels, as the space on those labels is lim-ited. Blood and blood components are biological products and
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Are defending the land with our blood, Cardiorespiratory Endurance, Human Kinetics, Blood, Peripheral Blood Mononuclear Cell PBMC, FAO WORKING FOR SDG 14, Quality control of animal immunoglobulins and immunosera for human, International Nonproprietary Names (INN) for, Working, International Nonproprietary Names (INN) for biological and biotechnological substances, Haemovigilance, Biological